Cargando…

Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response

Rheumatoid arthritis (RA) is a disabling autoimmune disease with invasive arthritis as the main manifestation and synovitis as the basic pathological change, which can cause progressive destruction of articular cartilage and bone, ultimately leading to joint deformity and loss of function. Since its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Huanhuan, Su, Rui, Xue, Hongwei, Gao, Chong, Li, Xiaofeng, Wang, Caihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719371/ https://www.ncbi.nlm.nih.gov/pubmed/34975886 http://dx.doi.org/10.3389/fimmu.2021.789334

Ejemplares similares

T-Follicular Regulatory Cells: Potential Therapeutic Targets in Rheumatoid Arthritis
por: Ding, Tingting, et al.
Publicado: (2019)

New Insights From Single-Cell Sequencing Data: Synovial Fibroblasts and Synovial Macrophages in Rheumatoid Arthritis
por: Cheng, Liyun, et al.
Publicado: (2021)

Immunological risk factors for nonalcoholic fatty liver disease in patients with psoriatic arthritis: New predictive nomograms and natural killer cells
por: Li, Baochen, et al.
Publicado: (2022)

Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation
por: Yao, Yao, et al.
Publicado: (2020)

Editorial: Gut microbiome, metabolites, and immune response in lupus, rheumatoid arthritis, and Sjögren syndrome
por: Zhao, Lidan, et al.
Publicado: (2023)

Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities
por: Zhao, Ting, et al.
Publicado: (2022)

Association of the characteristics of the blood metabolome and gut microbiome with the outcome of methotrexate therapy in psoriasis
por: Qiu, Qinwei, et al.
Publicado: (2022)

Preliminary Study on the Imbalance Between Th17 and Regulatory T Cells in Antiphospholipid Syndrome
por: Yan, Huanhuan, et al.
Publicado: (2022)

The bridge of the gut–joint axis: Gut microbial metabolites in rheumatoid arthritis
por: Xu, Xiaoyu, et al.
Publicado: (2022)

Methotrexate Combined with 4-Hydroperoxycyclophosphamide Downregulates Multidrug-Resistance P-Glycoprotein Expression Induced by Methotrexate in Rheumatoid Arthritis Fibroblast-Like Synoviocytes via the JAK2/STAT3 Pathway
por: Qin, Kaili, et al.
Publicado: (2018)

Frontiers of Autoantibodies in Autoimmune Disorders: Crosstalk Between Tfh/Tfr and Regulatory B Cells
por: Ding, Tingting, et al.
Publicado: (2021)

The change of plasma metabolic profile and gut microbiome dysbiosis in patients with rheumatoid arthritis
por: Zhu, Jing, et al.
Publicado: (2022)

Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis
por: Salem, Heba F., et al.
Publicado: (2022)

Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
por: Huang, Jie, et al.
Publicado: (2021)

Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis
por: Jiang, Qi, et al.
Publicado: (2022)

Sustained Drug Treatment Alters the Gut Microbiota in Rheumatoid Arthritis
por: Mei, Liyan, et al.
Publicado: (2021)

MicroRNA Expression Differences in Blood-Derived CD19+ B Cells of Methotrexate Treated Rheumatoid Arthritis Patients
por: Heinicke, Fatima, et al.
Publicado: (2021)

The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis
por: Fuentelsaz-Romero, Sara, et al.
Publicado: (2021)

Ferroptosis in Rheumatoid Arthritis: A Potential Therapeutic Strategy
por: Zhao, Ting, et al.
Publicado: (2022)

Targeting transcription factors for therapeutic benefit in rheumatoid arthritis
por: Balendran, Thivya, et al.
Publicado: (2023)

Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis
por: Han, Liang, et al.
Publicado: (2023)

Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
por: Rexhepi, Sylejman, et al.
Publicado: (2012)

Role of Key TYMS Polymorphisms on Methotrexate Therapeutic Outcome in Portuguese Rheumatoid Arthritis Patients
por: Lima, Aurea, et al.
Publicado: (2014)

Therapeutic Maintenance Level of Methotrexate in Rheumatoid Arthritis: A RBSMR Study
por: Oulkadi, Lamia, et al.
Publicado: (2022)

Methotrexate Hepatotoxicity in Patients with Rheumatoid Arthritis
por: Sotoudehmanesh, R, et al.
Publicado: (2010)

Adherence to Methotrexate therapy in Rheumatoid Arthritis
por: Arshad, Nasim, et al.
Publicado: (2016)

Application value of blood metagenomic next-generation sequencing in patients with connective tissue diseases
por: Su, Rui, et al.
Publicado: (2022)

Relationship between gut microbiota and rheumatoid arthritis: A bibliometric analysis
por: Dong, Ying, et al.
Publicado: (2023)

Microbiome in Rheumatoid Arthritis and Celiac Disease: A Friend or Foe
por: Elsouri, Kawther, et al.
Publicado: (2021)

Elevated Peripheral T Helper Cells Are Associated With Atrial Fibrillation in Patients With Rheumatoid Arthritis
por: Wang, Xin, et al.
Publicado: (2021)

Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate
por: Smolen, Josef S, et al.
Publicado: (2018)

Rheumatoid meningitis: a rare neurological complication of rheumatoid arthritis
por: Fan, Siyuan, et al.
Publicado: (2023)

Combination of Methotrexate and Leflunomide Is Efficient and Safe for 60 Patients with Rheumatoid Arthritis
por: Chen, Fang, et al.
Publicado: (2022)

Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
por: Bulatović Ćalasan, Maja, et al.
Publicado: (2013)

Comparative efficacy and safety of JAK inhibitors as monotherapy and in combination with methotrexate in patients with active rheumatoid arthritis: A systematic review and meta-analysis
por: Liu, Li, et al.
Publicado: (2022)

Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients
por: Ling, Stephanie F., et al.
Publicado: (2019)

Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?
por: Lima, Aurea, et al.
Publicado: (2015)

Stratified distribution of Th17 and Treg cells in patients with multi-stage rheumatoid arthritis
por: Su, Rui, et al.
Publicado: (2023)

Prevention and treatment of rheumatoid arthritis through traditional Chinese medicine: role of the gut microbiota
por: Liang, Yujiao, et al.
Publicado: (2023)

The Gut Microbiome and Metabolites Are Altered and Interrelated in Patients With Rheumatoid Arthritis
por: Yu, Die, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hjdnd8vpcpcsq0g67rail6crm5